Koshinski Asset Management
DWTX

Koshinski Asset Management’s Dogwood Therapeutics DWTX Stock Holding History

Koshinski Asset Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,637
Closed -$9.66K – 641
2022
Q4 		$9.66K Hold
1,637
– – ﹤0.01% 607
2022
Q3 		$16K Hold
1,637
– – ﹤0.01% 548
2022
Q2 		$173K Buy
+1,637
New +$171K 0.02% 562

Other funds holding DWTX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Koshinski Asset Management's DWTX Position: Q1 2023 in Review

Koshinski Asset Management sold out of Dogwood Therapeutics (DWTX) in Q1 2023, closing a stake of 1,637 shares — an estimated $9.66K sold.

Koshinski Asset Management first reported a position in DWTX in Q2 2022 and held it in 3 quarters. The position peaked at $173K in Q2 2022. 23 funds tracked by Wall St. Rank hold DWTX as of Q1 2023.

  • Koshinski Asset Management reported no remaining Dogwood Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Koshinski Asset Management sold 1,637 Dogwood Therapeutics shares in Q1 2023, an estimated $9.66K.
  • Koshinski Asset Management first reported a position in Dogwood Therapeutics in Q2 2022 and held it in 3 quarters.
  • Koshinski Asset Management's Dogwood Therapeutics position peaked at $173K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2023.

Based on Koshinski Asset Management's 13F filing for Q1 2023, filed 12 Apr 2023.